New Delhi, March 5 The domestic pharmaceutical industry is facing potential losses ranging from Rs 2,500 crore to Rs 5,000 crore due to various supply and freight disruptions caused by the conflict in the Middle East, according to the Pharmaceuticals Export Promotion Council of India...
ayush formulations
export value
freight costs
gcc countries
generic formulations
india
logistics
middle east conflict
pharmaceutical exports
pharmaceuticalindustrypharmaceutical trade
supply chain disruption
surgical products
vaccines
wana region
Minister of Chemicals and Fertilizers, Jagat Prakash Nadda, stated that the budgetary allocation of 13 thousand crore rupees for BioPharma SHAKTI and three dedicated Chemical Parks is a strategic investment in India's future. Speaking at the post-Budget webinar on the theme "Sustaining and...
biopharma shakti
biosimilars
central drugs standard control organization
chemical parks
chemical sector
clinical trials
drug fermentation
economic growth
generic medicines
india economy
industrial symbiosis
niper
pharmaceuticalindustry
trade agreements
viksit bharat
New Delhi, February 27 Glenmark Pharmaceuticals announced on Friday that its US-based unit is preparing to introduce a generic sodium phosphate injection in the American market.The Mumbai-based pharmaceutical company stated that its product is therapeutically equivalent to Hosira Inc.'s...
bse stock exchange
drug sales
generic drug
glenmark pharmaceuticals
india
injection
iqvia sales data
pharmaceutical distribution
pharmaceuticalindustrypharmaceutical market
pharmaceutical products
regulatory filing
sodium phosphate injection
united states
us market
New Delhi, February 25 Pharmaceutical company Lupin Ltd announced on Wednesday that the Maharashtra GST Department has initiated an inspection and search at its registered office in Mumbai.The inspection and search, which began at 11:50 am on February 25, 2026, is aimed at obtaining documents...
New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
anda
brivaracetam
briviact
bse
drug approval
generic medication
india
lupin
oral solution
pharmaceuticalindustrypharmaceutical sales
seizures
us market
usfda
New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
Mumbai, February 23 The Central Drugs Standard Control Organisation (CDSO) has conducted an audit of almost 90 per cent of cough syrup manufacturers in the country, and it hopes to eliminate the "problem" in cough syrup by the next season, a top official said on Monday.Speaking at the 11th...
audit
capa (corrective and preventive action)
central drugs standard control organisation
cough syrup
drugs controller general of india
good manufacturing practices
india
mumbai
pharmaceuticalindustrypharmaceutical manufacturing
pharmaceutical quality
quality control
regulatory compliance
risk-based inspection
Mumbai, February 23 Union Minister J P Nadda on Monday urged the domestic pharmaceutical industry to anchor the redesigned global supply chain not only with scale, but also with quality, reliability, and innovation.Addressing virtually the 11th edition of the Global Pharmaceutical Quality...
artificial intelligence
biopharmaceutical manufacturing
clinical trials
disease detection
global supply chain
healthcare
india
innovation
pharmaceuticalindustrypharmaceutical quality
predictive diagnostics
quality systems
regulatory affairs
research and development
supply chain resilience
New Delhi, February 21 The commerce ministry said on Saturday that the country's pharmaceutical exports grew by 9.4 per cent in 2024-25 to USD 30.47 billion, and the industry is aiming for double-digit expansion in 2026-27.Issues related to pharmaceutical exports were discussed between...
ahmedabad
commerce ministry
european union
export growth
global markets
india
india exports
pharmaceutical exports
pharmaceuticalindustrypharmaceutical market
pharmaceuticals and medical devices
regulatory markets
trade
trade engagements
united states
Washington, February 20 – President Donald Trump said he threatened to impose a 100% tariff on French wine and champagne in order to force changes in global drug pricing, offering a vivid example of how he uses trade leverage to reshape international economic arrangements.Speaking at a steel...
donald trump
drug pricing
economic policy
european union
france-united states relations
germany
international trade
pharmaceuticalindustry
prescription drugs
spain
steel industry
tariffs
trade negotiations
united states trade policy
us supreme court
wine tariffs
New Delhi, February 16 Alkem Laboratories said on Monday that the US health regulator has issued a Form 483 with six observations after inspecting the manufacturing unit of its wholly-owned subsidiary, located in Chakan.The US Food and Drug Administration (USFDA) completed a pre-approval...
alkem laboratories
bse
chakan
data integrity
drug firm
enzene biosciences
fd&c act
form 483
india
manufacturing unit
pharmaceuticalindustrypharmaceutical manufacturing
quality systems
regulatory inspection
us food and drug administration (usfda)
New Delhi, February 15 Pharmaceutical firm Adven Biotech has claimed to be the first homeopathy brand in the country to receive certification from the National Accreditation Board for Testing and Calibration Laboratories (NABL), further strengthening India's efforts to achieve global-quality...
New Delhi, February 13 As many as five companies, including Premier Industrial Corporation and mattress maker Duroflex, have secured Sebi approval to launch their IPOs, an update with the markets regulator showed on Friday.Besides, pharmaceutical company Virupaksha Organics, Mumbai-based...
New Delhi, February 13 Akums Drugs & Pharmaceuticals reported a 29.5 per cent increase in consolidated net profit to Rs 86 crore for the third quarter ended December 2025, on Friday.The company earned a net profit of Rs 66 crore in the October-December quarter of the previous fiscal year.Its...
New Delhi, February 12 Lincoln Pharmaceuticals announced on Thursday that its consolidated net profit increased by nearly 38 per cent to Rs 29 crore in the third quarter of fiscal 2025-26.The company had reported a net profit of Rs 21 crore in the year-ago period.Revenue from operations for...
New Delhi, February 9 GlaxoSmithKline Pharmaceuticals announced on Monday a 29 per cent increase in consolidated profit after tax to Rs 296 crore for the third quarter ended December 31, 2025.The pharmaceutical company reported a profit after tax of Rs 230 crore for the October-December...